Currently out of the existing stock ratings of Navin Jacob, 33 are a HOLD (45.21%), 36 are a BUY (49.32%), 4 are a SELL (5.48%).

Navin Jacob

Work Performance Price Targets & Ratings Chart

Analyst Navin Jacob, has had 73.15% of price targets met with an average potential upside of 22.5%, reached in 513 days on average. Previously, Navin Jacob worked at UBS, DEUTSCHE BANK.

Navin Jacob has documented 143 price targets and ratings displayed on 19 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on ABBV, AbbVie at 02-Feb-2025.

Wall Street Analyst Navin Jacob

Analyst best performing recommendations are on RAPT.
The best stock recommendation documented was for RAPT on 11/25/2019. The price target of $208 was fulfilled within 4 days with a profit of $27.76 (11.77%), with a performance score of 29.44.

Average potential price target upside

ABBV AbbVie LLY Eli Lilly and Company RPRX AGN Allergan plc ICPT MYL Viatris TEVA Teva Pharma Industries Ltd ADR ZTS MRK Merck mpany CELG Celgene REGN Regeneron Pharmaceuticals VRTX Vertex Pharmaceuticals APLT Applied Therapeutics ELAN Elanco Animal Health MDGL Madrigal Pharmaceuticals VTRS Viatris GILD Gilead Sciences PFE Pfizer RAPT

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 19-Feb-2026

$335

$39.97 (13.55%)

$325

3 days ago
(15-Nov-2026)

Buy Since 17-Nov-2020

$338

$42.97 (14.56%)

$282

17 days ago
(01-Nov-2026)

20/21 (95.24%)

$43.11 (14.62%)

335

Buy Since 07-Dec-2021

$340

$44.97 (15.24%)

$300

17 days ago
(01-Nov-2026)

11/13 (84.62%)

$45.11 (15.30%)

479

Buy Since 05-Apr-2022

$346

$50.97 (17.28%)

$310

17 days ago
(01-Nov-2026)

33/35 (94.29%)

$51.11 (17.33%)

486

Buy Since 15-Nov-2023

$325

$29.97 (10.16%)

$290

17 days ago
(01-Nov-2026)

32/33 (96.97%)

$30.11 (10.21%)

244

Show more analysts

Please expand the browser size to see the chart

✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?